|
2019 Journal Article Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathologyYaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samartunga, Hemamali, Yaxley, Anna J., Coughlin, Geoff, Delahunt, Brett, Egevad, Lars, McEwan, Louise and Wong, David (2019). Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology. The Journal of Urology, 201 (4), 815-820. doi: 10.1097/JU.0000000000000053 |
|
2019 Journal Article Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be gradedSamaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Srigley, John R., Billis, Athanase, Bostwick, David G., Camparo, Philippe, Cheng, Liang, Clouston, David, Denham, James, Furusato, Bungo, Hartmann, Arndt, Jufe, Laura, Kench, James, Kenwright, Diane N., Kristiansen, Glen, Leite, Katia R.M., MacLennan, Gregory T., Merrimen, Jennifer, Moch, Holger, Oxley, Jon, Pan, Chin-Chen, Paner, Gladell, Ro, Jae, Sesterhenn, Isabell A. M., Shanks, Jonathan, Thunders, Michelle, Tsuzuki, Toyonori, Wheeler, Thomas ... Varma, Murali (2019). Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology, 52 (2), 192-196. doi: 10.1016/j.pathol.2019.11.001 |
|
2019 Journal Article Evolution, controversies and the future of prostate cancer gradingEgevad, Lars, Delahunt, Brett, Yaxley, John and Samaratunga, Hemamali (2019). Evolution, controversies and the future of prostate cancer grading. Pathology International, 69 (2), 55-66. doi: 10.1111/pin.12761 |
|
2019 Journal Article Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)Becherel, Olivier J., Fogel, Brent L., Zeitlin, Scott I., Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin F. (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). Cerebellum, 18 (3), 448-456. doi: 10.1007/s12311-019-01012-w |
|
2019 Journal Article Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer ReportingBerney, Dan M., Comperat, Eva, Feldman, Darren R., Hamilton, Robert J., Idrees, Muhammad T., Samaratunga, Hemamali, Tickoo, Satish K., Yilmaz, Asli and Srigley, John R. (2019). Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting. Histopathology, 74 (1), 171-183. doi: 10.1111/his.13736 |
|
2019 Journal Article Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinomaDagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Varma, Murali and Samaratunga, Hemamali (2019). Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma. Pathology, 51 (4), 349-352. doi: 10.1016/j.pathol.2019.01.004 |
|
2019 Journal Article Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinomaDagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Coughlin, Geoff, Dunglison, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon and Samaratunga, Hemamali (2019). Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma. Histopathology, 74 (2), 284-290. doi: 10.1111/his.13737 |
|
2019 Journal Article Grading of renal cell carcinomaDelahunt, Brett, Eble, John N., Egevad, Lars and Samaratunga, Hemamali (2019). Grading of renal cell carcinoma. Histopathology, 74 (1), 4-17. doi: 10.1111/his.13735 |
|
2019 Journal Article Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancerYaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samaratunga, Hemamali, Yaxley, William J., Coughlin, Geoff, Yaxley, Anna J., Gianduzzo, Troy, Kua, Boon, McEwan, Louise and Wong, David (2019). Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer. BJU International, 124 (3), 401-407. doi: 10.1111/bju.14828 |
|
2018 Journal Article Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarkerSina, Abu Ali Ibn, Carrascosa, Laura G., Liang, Ziyu, Grewal, Yadveer S., Wardiana, Andri, Shiddiky, Muhammad J. A., Gardiner, Robert A., Samaratunga, Hemamali, Gandhi, Maher K., Scott, Rodney J., Korbie, Darren and Trau, Matt (2018). Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nature Communications, 9 (1) 4915, 4915. doi: 10.1038/s41467-018-07214-w |
|
2018 Journal Article The current status of renal cell carcinoma and prostate carcinoma gradingDelahunt, Brett, Egevad, Lars, Yaxley, John and Samaratunga, Hemamali (2018). The current status of renal cell carcinoma and prostate carcinoma grading. International Braz J Urol, 44 (6), 1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01 |
|
2018 Journal Article MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literaturePokorny, Morgan, Kua, Boon, Esler, Rachel, Yaxley, John, Samaratunga, Hemamali, Dunglison, Nigel, Gianduzzo, Troy, Coughlin, Geoff, Holt, Ross, Laing, Barbara, Ault, Darren, Brown, Nicholas, Parkinson, Rob and Thompson, Les (2018). MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature. World Journal of Urology, 37 (7), 1263-1279. doi: 10.1007/s00345-018-2497-y |
|
2018 Journal Article Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?Ng, K. L., Del Vecchio, S. J., Samaratunga, H., Morais, C., Rajandram, R., Vesey, D. A., Wood, S. T. and Gobe, G. C. (2018). Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?. Pathology, 50 (5), 504-510. doi: 10.1016/j.pathol.2018.01.007 |
|
2018 Journal Article Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk predictionKoo, Kevin M., Wang, Jing, Richards, Renée S., Farrell, Aine, Yaxley, John W., Samaratunga, Hema, Teloken, Patrick E., Roberts, Matthew J., Coughlin, Geoffrey D., Lavin, Martin F., Mainwaring, Paul N., Wang, Yuling, Gardiner, Robert A. and Trau, Matt (2018). Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction. ACS Nano, 12 (8), 8362-8371. doi: 10.1021/acsnano.8b03698 |
|
2018 Journal Article Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled studyCoughlin, Geoffrey D., Yaxley, John W., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Teloken, Patrick, Dunglison, Nigel, Williams, Scott, Lavin, Martin F. and Gardiner, Robert A. (2018). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. The Lancet Oncology, 19 (8), 1051-1060. doi: 10.1016/S1470-2045(18)30357-7 |
|
2018 Journal Article Utility of Pathology Imagebase for standardisation of prostate cancer gradingEgevad, Lars, Delahunt, Brett, Berney, Daniel M., Bostwick, David G., Cheville, John, Comperat, Eva, Evans, Andrew J., Fine, Samson W., Grignon, David J., Humphrey, Peter A., Hörnblad, Jonas, Iczkowski, Kenneth A., Kench, James G., Kristiansen, Glen, Leite, Katia R.M., Magi-Galluzzi, Cristina, Mckenney, Jesse K., Oxley, Jon, Pan, Chin-Chen, Samaratunga, Hemamali, Srigley, John R., Takahashi, Hiroyuki, True, Lawrence D., Tsuzuki, Toyonori, van der Kwast, Theo, Varma, Murali, Zhou, Ming and Clements, Mark (2018). Utility of Pathology Imagebase for standardisation of prostate cancer grading. Histopathology, 73 (1), 8-18. doi: 10.1111/his.13471 |
|
2018 Journal Article A novel technique for biobanking of large sections of radical prostatectomy specimensLindh, Claes, Delahunt, Brett, Samaratunga, Hemamali, Yaxley, John, Gudjónsdóttir, Jóna, Clements, Mark, Lindberg, Johan and Egevad, Lars (2018). A novel technique for biobanking of large sections of radical prostatectomy specimens. Histopathology, 72 (3), 481-489. doi: 10.1111/his.13386 |
|
2018 Journal Article Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniquesYaxley, J. W., Dagher, J., Delahunt, B., Egevad, L., Srigley, J. and Samaratunga, H. (2018). Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques. World Journal of Urology, 36 (1), 15-20. doi: 10.1007/s00345-017-2119-0 |
|
2017 Journal Article Fuhrman grading is inappropriate for papillary renal cell carcinomaDelahunt, Brett, Egevad, Lars, Srigley, John R. and Samaratunga, Hemamali (2017). Fuhrman grading is inappropriate for papillary renal cell carcinoma. World Journal of Urology, 36 (8), 1335-1336. doi: 10.1007/s00345-017-2153-y |
|
2017 Journal Article Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendationsEgevad, Lars, Delahunt, Brett, Kristiansen, Glen, Samaratunga, Hemamali and Varma, Murali (2017). Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations. Pathology, 50 (1), 60-73. doi: 10.1016/j.pathol.2017.09.008 |
